Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men.
Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We …

Background Mutations in BRCA 1 and BRCA 2 (BRCA 1/2) genes are associated with an
increased risk of breast and ovarian cancers in women. The cancer characteristics of men …

The topic of breast cancer prevention is very broad. All aspects of the topic, therefore, cannot
be adequately covered in a single review. The objective of this review is to discuss …

Purpose This review will inform radiologists about the evidence base regarding radiographic
imaging for transgender individuals and considerations for providing culturally sensitive care …

Background Male breast cancer incidence is rising. There may be a potential role in
selective screening in men at elevated risk for breast cancer, but the effectiveness of such …

Purpose Limited data exist on the molecular biology, treatment, and outcomes of breast
cancer in men, and much of our understanding in this area remains largely an extrapolation …

Simple Summary Male breast cancer is a rare disease, representing around 0.5% of the
malignances in men. Although they receive the same treatment as women with breast …

Harmful mutations of the BRCA tumor suppressor genes result in a greater lifetime risk for
malignancy—breast and ovarian cancers in particular. An increased risk for male breast …